sov digital currency- Top Featured

Fourth, other fields also involve industrial chains such as electronic information generation, a new generation of intelligent networked vehicles and new energy vehicles, and also mention accelerating the merger of securities companies.First, the plan mentioned that by 2027, we will strive to land a number of representative M&A cases in key industries, form a M&A transaction scale of 300 billion yuan, and activate total assets of over 2 trillion yuan;Third, the transaction volume of the two cities has returned to the level of 2 trillion, and the market can be abundant, which is not a concern.

It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.

The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.Don't forget to like the fans after reading it. The new fans click to pay attention to Tiger Brother, and the investment will not get lost in the future.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;